CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Data collection and rhinopharyngeal swabWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug2930 observational Wiki 0.58

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D002318 Cardiovascular Diseases NIH 0.21

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0001626 Abnormality of the cardiovascular system HPO 0.21

There is one clinical trial.

Clinical Trials

1 Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children, a Cross-sectional, Prospective, Multicentre, Observational Study in Primary Care.

This study is expected to provide, for the first time, data on Cov2-SARS circulation in asymptomatic children and children with moderate respiratory symptoms in order to construct the severity pyramid of this novel pathogen. This information will be essential in the coming weeks to understand the dynamics of the transmission of this pathogen at the population level and to highlight the relevance of public health interventions, particularly with regard to the systematic closure of schools and childcare facilities.

NCT04318431 Covid19 Diagnostic Test: Data collection and rhinopharyngeal swab

Primary Outcomes

Description: Proportion of asymptomatic children or children with mild respiratory symptoms (mildly-symptomatic children) with a positive SARS-Cov2 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) on rhino pharyngeal swab or/and IgM/IgG positive serology in the Ile-de-France region during an epidemic period.

Measure: Proportion of asymptomatic children or children with mild respiratory symptoms

Time: 14 days

Secondary Outcomes

Description: The proportion of confirmed Cov2-SARS cases in mildly-symptomatic and asymptomatic children in different age groups (defined as 6-23 months, 2-4 years, 5-9 years, 10-15 years).

Measure: Confirmed Cov2-SARS cases by age

Time: 14 days

Description: The proportion of confirmed Cov2-SARS cases based on the symptoms presented by the patients

Measure: Confirmed Cov2-SARS cases by symptoms

Time: 14 days

Description: The viral load of children with SARS-Cov2 positive Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) depending on the symptoms and the age of the patients

Measure: Viral load

Time: 14 days

Description: The proportion of co-infection with other respiratory viruses among children with SARS -Cov2 RT-PCR positive

Measure: Other respiratory viruses

Time: 14 days

Description: Proportion of patients with Sars-Cov2 IgM +

Measure: Sars-Cov2 IgM

Time: 14 days

Description: Proportion of patients with Sars-Cov2 IgG +

Measure: Sars-Cov2 IgG

Time: 14 days

No related HPO nodes (Using clinical trials)